E

On finding new targets and boosting existing therapies

Science drives oncology new product development and the AACR special conferences are always a good place…

October 22, 2020
E

Potential new targets and biomarkers for immunotherapy

How we can learn more from failure in clinical trials so we can improve outcomes further with emerging agents in early development

October 20, 2020
E

Competition rapidly heats up in the KRAS space!

Overcoming acquired resistance to KRAS inhibitors will be key to success - here's one potential way to do that.

January 20, 2020
E

New ways of thinking about the immune landscape

How early evolutionary changes in cancer can impact hot/cold regions and patient outcomes

October 13, 2020